Movano Health (Nasdaq: MOVE) has been granted a listing extension by Nasdaq, subject to meeting certain compliance requirements by specific deadlines.
The extension follows a hearing on August 19, 2025, where the company presented its plan to regain compliance with Nasdaq's rules.
Movano Health is actively working on filing its Quarterly Reports on Form 10-Q and has filed a Preliminary Proxy Statement for an upcoming shareholder meeting.
Listing Extension Granted
Nasdaq has granted Movano Health an extension, contingent on meeting the Period Filing Rule and Bid Price Rule by specific dates.
Compliance Efforts
The company is diligently working to file its Quarterly Reports and has filed a Preliminary Proxy Statement for a shareholder meeting.
Upcoming Shareholder Meeting
Shareholders will have the opportunity to approve a reverse stock split proposal at the upcoming meeting on September 26, 2025.
- Movano Health's compliance efforts demonstrate a commitment to meeting Nasdaq's requirements and maintaining its listing on the exchange.
- The extension granted by Nasdaq provides the company with a timeline to achieve the necessary compliance milestones, including filing Quarterly Reports and addressing the Bid Price Rule.
Movano Health's successful listing extension and proactive compliance efforts signal a positive trajectory for the company. Shareholders' approval of the reverse stock split proposal can further strengthen Movano's position in meeting Nasdaq's requirements.